diazomethane has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bednarski, E; Lynch, G; Ribak, CE | 1 |
| Anagli, J; Betts, RL; Chopp, M; Han, Y; Li, K; Seyfried, DM; Tang, N; Veyna, R; Weinsheimer, S | 1 |
2 other study(ies) available for diazomethane and Nerve Degeneration
| Article | Year |
|---|---|
Suppression of cathepsins B and L causes a proliferation of lysosomes and the formation of meganeurites in hippocampus.
Topics: Animals; Cathepsin B; Cathepsin L; Cathepsins; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Diazomethane; Endopeptidases; Enzyme Precursors; Hippocampus; Hydrolases; Lysosomes; Microscopy, Electron; Nerve Degeneration; Neurites; Organ Culture Techniques; Pyramidal Cells; Rats; Rats, Sprague-Dawley | 1997 |
A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia.
Topics: Animals; Blood Glucose; Brain; Brain Ischemia; Cardiovascular Physiological Phenomena; Cathepsin B; Cathepsin L; Cathepsins; Cell Death; Cerebrovascular Circulation; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Diazomethane; Dipeptides; Dose-Response Relationship, Drug; Endopeptidases; Infarction, Middle Cerebral Artery; Injections, Intravenous; Male; Nerve Degeneration; Neuroprotective Agents; Neurotoxins; Rats; Rats, Wistar; Reperfusion Injury; Tumor Cells, Cultured | 2001 |